Delirium is prevalent in older hospital inpatients and associated with adverse outcomes: results of a prospective multi-centre study on World Delirium Awareness Day by Geriatric Medicine Research Collaborative, . & ,
RESEARCH ARTICLE Open Access
Delirium is prevalent in older hospital
inpatients and associated with adverse
outcomes: results of a prospective multi-
centre study on World Delirium Awareness
Day
Geriatric Medicine Research Collaborative
Abstract
Background: Delirium is a common severe neuropsychiatric condition secondary to physical illness, which
predominantly affects older adults in hospital. Prior to this study, the UK point prevalence of delirium was unknown.
We set out to ascertain the point prevalence of delirium across UK hospitals and how this relates to adverse
outcomes.
Methods: We conducted a prospective observational study across 45 UK acute care hospitals. Older adults aged 65
years and older were screened and assessed for evidence of delirium on World Delirium Awareness Day (14th
March 2018). We included patients admitted within the previous 48 h, excluding critical care admissions.
Results: The point prevalence of Diagnostic and Statistical Manual on Mental Disorders, Fifth Edition (DSM-5)
delirium diagnosis was 14.7% (222/1507). Delirium presence was associated with higher Clinical Frailty Scale (CFS):
CFS 4–6 (frail) (OR 4.80, CI 2.63–8.74), 7–9 (very frail) (OR 9.33, CI 4.79–18.17), compared to 1–3 (fit). However, higher
CFS was associated with reduced delirium recognition (7–9 compared to 1–3; OR 0.16, CI 0.04–0.77). In multivariable
analyses, delirium was associated with increased length of stay (+ 3.45 days, CI 1.75–5.07) and increased mortality
(OR 2.43, CI 1.44–4.09) at 1 month. Screening for delirium was associated with an increased chance of recognition
(OR 5.47, CI 2.67–11.21).
Conclusions: Delirium is prevalent in older adults in UK hospitals but remains under-recognised. Frailty is strongly
associated with the development of delirium, but delirium is less likely to be recognised in frail patients. The presence
of delirium is associated with increased mortality and length of stay at one month. A national programme to increase
screening has the potential to improve recognition.
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Background
Delirium is a neuropsychiatric syndrome, which dispro-
portionately affects older people in hospital. The Diag-
nostic and Statistical Manual on Mental Disorders, Fifth
Edition (DSM-5) defines delirium as an acute and/or
fluctuating change in awareness, arousal, and other cog-
nitive deficits due to physical illness or drugs [1, 2]. Psy-
chomotor subtypes are hyperactive, characterised by
motor agitation, perceptual differences, and delusions,
and hypoactive, featuring predominantly motor retard-
ation and thought process abnormality; or mixed [3]. It
is very common, but prevalence differs across popula-
tions: 10–31% for most acute settings outside critical
care [4]. Prior to our study, the largest point prevalence
study of delirium using DSM criteria reported a preva-
lence of 19.6% amongst 280 general hospital adult inpa-
tients in a single centre in Ireland [5].
Delirium is consistently associated with increased
mortality, accounting for age, co-morbidity, and acute
illness [6]. It is also associated with increased length of
hospital stay, new institutionalisation, and distress to pa-
tients and families [4, 7]. Delirium commonly occurs in
people with dementia [8] and is considered to worsen
cognitive decline [9]. In people without dementia, an
episode of delirium is associated with eightfold increased
risk of later-life dementia diagnosis [10]. Few studies
have assessed the relationship between delirium and
frailty [11–14].
Delirium remains underdiagnosed in up to three quar-
ters of patients [15–18]. Incomplete understanding of
delirium and resultant educational needs of healthcare
professionals, alongside avoidant behaviours towards a
challenging patient group, are likely contributory [19].
National Institute for Health and Care Excellence
(NICE) Guidelines recommend that all patients aged 65
or over are screened for delirium upon hospital admis-
sion [20]; this can be done using the 4 A’s Test (4AT).
The 4AT is a validated screening tool, which can be
completed by any healthcare professional in less than
2 min [21]. Diagnosis should be made using DSM-5, re-
corded in inpatient notes, and communicated to the
general practitioner [22].
This study set out to identify the point prevalence of
delirium, rates of screening, and rates of recognition of
delirium in non-elective admissions of older people
within the UK. We aimed to assess patient and hospital
factors inclusive of frailty measures that were predictive
of delirium, screening, and recognition. Secondary out-
comes included one-month mortality and length of stay.
Methods
Study design and setting
We conducted a multi-centre study of delirium screen-
ing, recognition, and discharge documentation on
Wednesday 14th March 2018: World Delirium Aware-
ness Day. This is an annual international day, which
aims to increase awareness of delirium amongst health-
care professionals, patients, carers, and stakeholders
[23]. This day was chosen to encourage an increased at-
mosphere acknowledging the importance of delirium
screening and recognition within participating trusts and
to encourage quality improvement strategies for the fu-
ture. This involved acute care trusts within the UK who
volunteered to participate. Participation was open to all
hospitals within the UK, and the onus was put upon staff
within individual sites to volunteer to participant rather
than being selected. No financial incentives were pro-
vided to trusts to participate. Regional representatives
emailed the staff at all sites to encourage participation.
Data collected from each site were anonymised and en-
tered into pre-formatted Excel spreadsheets. Spread-
sheets were formatted so that data was entered in the
same way for all sites. These spreadsheets were collated
centrally. Our reporting is in line with Strengthening the
Reporting of Observational Studies in Epidemiology
(STROBE) guidelines (Additional file 3) [24].
Participants
Inclusion criteria were adults aged ≥ 65 years (in line
with NICE guidelines), admitted between 08:00 12th
March 2018 and 07:59 14th March 2018, and still hos-
pital inpatients at the time of assessment. Exclusion cri-
teria were patients admitted to critical care, imminently
approaching the end of life, or in whom it was impracti-
cal to assess for logistical reasons (e.g. patient undergo-
ing operation, not at bedside). The minimum data
required for inclusion was 4AT score and presence/ab-
sence of delirium.
Delirium screening and assessment
Patient assessment as part of the study took place be-
tween 08:00 and 20:00 on 14 March 2018. All included
patients were screened using the 4AT by the study team;
in all patients who scored ≥ 4/12, a further assessment
for delirium was conducted. Our approach to further as-
sessment for delirium was operationalised on DSM-5
(Additional file 1). The 4AT was performed by a health-
care professional or student with training and support
from the local geriatric medicine site lead. All formal
DSM-5 assessments were performed by a healthcare
professional; patients with 4AT score ≥ 4/12 identified
by students were reviewed by healthcare professionals.
Standardised training was provided centrally to all via
webcast and video resources. The presence or absence of
delirium was classified as definite (meets DSM-5 cri-
teria), possible (meets some DSM-5 criteria but not all),
or no delirium. Motor subtype was classified by the De-
lirium Motor Subtype Scale (DMSS) [19] as hypoactive
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(reduced alertness), hyperactive (increased alertness or
motor agitation), mixed (some features of both hypoac-
tive and hyperactive), or no clear motor subtype.
Additional data collection
Further patient details were recorded from the patient’s
hospital notes including age, gender, dementia status
(known history—any history documented in the notes/
probable—no documented diagnosis but history of pro-
gressive cognitive impairment impairing activities of
daily living documented/no dementia), and specialty at
time of assessment (acute medicine/geriatric medicine/
stroke/other medicine/orthopaedic surgery/general sur-
gery/other surgery). Clinical Frailty Scale (CFS) from 1
to 9 was determined prospectively from note review
(functional status documentation) and clinical assess-
ment by the student or healthcare professional assessing
the patient as part of the study [25]. We recorded if pa-
tients had been screened for delirium (using any recog-
nised tool) by the usual care team and if a diagnosis of
delirium was recorded in the medical notes by the usual
care team prior to 4AT assessment as part of this study.
Delirium was considered to have been recognised if a
DSM-5 diagnosis was made during the assessment, and
this had previously been documented by the usual care
team. Each site collected data on local factors: presence
of local delirium guidelines, local delirium patient leaf-
lets, delirium screening tools in admission documenta-
tion booklets, geriatric medicine team embedded into
the admissions unit, or a specialist delirium team. These
were defined locally. Length of stay, mortality, and docu-
mentation of delirium on discharge documentation were
collected up until 13th April 2018.
Statistical methods
Statistical analysis was performed using IBM SPSS Sta-
tistics 22 (Chicago, IL, USA). We assessed the differ-
ences between patients with and without delirium using
chi-squared tests for categorical data and independent t
tests for continuous data. Grouping of variables was de-
cided post hoc. Possible delirium was coded as no delir-
ium, and probable dementia was coded as dementia.
Frailty status was separated into three categories by CFS
(fit, 1–3; frail, 4–6; very frail, 7–9). Delirium subtype was
classified as hypoactive or other. Due to small numbers,
general and other surgery specialties were grouped for
the main analysis. General and other surgery were fur-
ther grouped with orthopaedic surgery for recognition
analysis; stroke was grouped with other medicine when
analysing discharge documentation.
Binary logistic regression was performed to assess the
effect of covariates upon delirium screening, prevalence,
and recognition, and the effect of screening upon recog-
nition. Patients who died within the follow-up period
were excluded from the length of stay analysis. Length
of stay was visually assessed for normality; Mann-
Whitney U test was used to assess the length of stay in
those with and without delirium. Effects of the presence
of delirium upon length of stay were assessed using ro-
bust (bootstrapped) analysis of covariance (ANCOVA),
adjusting for the variables above. Bootstrapping was per-
formed due to skewed distribution of length of stay
Fig. 1 Flow chart demonstrating participation in delirium day study. On
14th March 2018, 45 hospitals participated in World Delirium Day study.
Two thousand three hundred and eighty-five individuals met the study
criteria of admission between 08:00 on 12th March 2018 and 07:59 on
14th March 2018. Thirty-seven individuals were excluded as they were
judged to be imminently dying. Seven hundred and nineteen individuals
were excluded for logistical reasons. Seventy-seven were excluded as
they had not yet had their initial assessment. Forty-five were excluded
because the assessment was deemed to cause undue distress. One
thousand five hundred and seven individuals were screened with 4AT.
Of these, 366 had a score equal to or greater than four and underwent
further assessment of delirium using DSM-5 criteria. Of those who were
4AT positive, 222 were proven to have DSM-5 delirium
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using IBM SPSS Statistics 22, with the number of sam-
ples set at 1507, confidence interval set at 95%, and a
simple sampling method selected. Bootstrapping was not
performed for analysis of other outcomes. Association of
delirium with mortality was assessed using binary logis-
tic regression and Cox regression. A secondary analysis
was performed to assess the effects of recognition and
delirium subtype upon length of stay and mortality. Any
missing variables and outcome data were coded as miss-
ing data, but these participants were included in all ana-
lysis, provided data was available on the presence or
absence of delirium.
Ethical approval
All data were collected as part of a multi-centre audit to
assess compliance with NICE guidelines and registered
through clinical governance departments. Anonymised
data were securely transferred to the University of Bir-
mingham. Ethical approval was obtained for a secondary
analysis of the anonymised database from the University
of Birmingham Science, Technology, Engineering, and
Mathematics Ethical Review Committee (ERN_18-1415).
Results
A total of 45 hospitals participated (Additional file 2:
Figure S1), and 2385 patients were identified. Reasons
for exclusion included the following: pre-admission
(77), imminently dying (37), undue distress (45), and lo-
gistical reasons (719). Logistical reasons included the
patient or notes being unavailable, or unavailability of
staff. The final sample included 1507 patients (Fig. 1).
The mean age was 80.0 (SD ± 8.3); 54.2% were female,
16.3% had dementia or probable dementia, 43.0% were
acute medicine patients, and 68.1% had a CFS score of
4 or greater (Table 1; Additional file 2: Table S1). Mor-
tality to follow-up was 6.7% (97/1507). The rates of
missing data were low overall; the rates of missing data
are included within Additional file 2: Table S2.
Delirium prevalence
With 4AT assessment, 25.1% (379/1507) scored positive
(≥ 4/12). Prevalence of DSM-5 delirium was 14.7% (222/
1507); including those with possible delirium as well as
DSM-5 delirium, prevalence was 21.2% (320/1507). Con-
sidering delirium subtypes, 18.2% (40/220) were hyper-
active, 13.2% (29/220) were mixed type, 58.6% (129/220)
were hypoactive, and 10.0% (22/220) had no clear sub-
type (as assessed by local data collectors). The presence
of delirium was independently associated with increased
age (per year of life: OR 1.04, CI 1.02–1.06; p < 0.001),
dementia status (OR 1.95, CI 1.36–2.79; p < 0.001),
frailty, frail (OR 4.80, CI 2.63–8.74; p < 0.001), and very
frail (OR 9.33, CI 4.79–18.17; p < 0.001). Delirium preva-
lence was not affected by any hospital factors or gender
(Additional file 2: Table S2). Prevalence of delirium dif-
fered between specialties (Fig. 2a). However, specialty
did not affect the likelihood of delirium after adjusting
for age and frailty (Additional file 2: Table S3).
Table 1 Demographics of patients included in this study. Results are shown for the percentage of study participants who met each
characteristic. These have been further separated for comparison between participants with and without delirium. Overall, the mean
age of participants was 80.0; 54.2% were female, and 16.3% had known or probable dementia; 43.0% were admitted under acute
medicine at the time of assessment; 68.0% had a CFS score of 4 or greater
All No delirium Delirium (DSM-5) p
Age (mean, SD) 80.0 (8.3) 79.3 (8.3) 84.0 (7.4) < 0.001
Gender
Female 54.2% (798) 52.9% (663) 62.0% (218) 0.013
Dementia
Known or probable 16.3% (244) 13.0% (166) 35.5% (78) < 0.001
Specialty
Acute medicine 43.0% (648) 42.2% (542) 47.8% (106) < 0.001
Geriatric medicine 17.6% (265) 16.0% (206) 26.6% (59)
Other medicine 20.9% (315) 22.1% (284) 14.0% (31)
Stroke 3.7% (56) 4.0% (52) 1.8% (4)
General and other surgery 8.5% (128) 9.4% (121) 3.2% (7)
Orthopaedic surgery 6.3% (95) 6.2% (80) 6.8% (15)
Frailty
Fit (CFS 1–3) 31.9% (468) 36.3% (453) 6.9% (15) < 0.001
Frail (CFS 4–6) 54.3% (796) 53.0% (662) 62.0% (134)
Very frail (CFS 7–9) 13.7% (201) 10.7% (134) 31.0% (67)
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Delirium screening
There was evidence of delirium screening by the usual
care team in 27.3% (410/1507). Increasing age (per year of
life: OR 1.04, CI 1.02–1.06; p < 0.001) and the presence of
a local delirium specialist team (OR 2.03, CI 1.48–2.80;
p < 0.001) were associated with an increased chance of
screening. Admission under general or other surgery com-
pared to acute medicine resulted in a reduced chance of
delirium screening (OR 0.38, CI 0.21–0.70; p = 0.002)
(Fig. 2b). Chances of delirium screening by the usual care
team were not affected by gender, dementia status, frailty,
or other hospital factors (Additional file 2: Table S4).
Delirium recognition
The usual care team recognised DSM-5 delirium in 34.2%
of cases (76/222). Increased screening rates were associ-
ated with increased recognition rates by the usual care
team (OR 5.47, CI 2.67–11.21; p < 0.001). The presence of
a delirium team was associated with a decreased chance of
recognition (OR 0.33, CI 0.23–0.84; p = 0.020). Delirium
was less likely to be recognised in very frail compared to
fit patients (OR 0.16, CI 0.04–0.77; p = 0.021) and general,
other, and orthopaedic surgery patients compared to acute
medicine (OR 0.04, CI 0.01–0.36; p = 0.004) (Fig. 2a). Age,
gender, and dementia status did not impact upon delirium
recognition. Delirium recognition was not affected by de-
lirium subtype (Additional file 2: Table S5).
Discharge documentation
Discharge documentation was assessed in 69.4% (154/
222) with DSM-5 delirium. Delirium was documented
on discharge summaries in 28.6% (44/154) of these.
Documentation on discharge summaries was not associ-
ated with any hospital or patient factors (Additional file 2:
Table S6).
Delirium and length of stay
The median length of stay in patients with DSM-5 delir-
ium was 11 days (IQR 5–21), compared to 7 days (IQR
3–14) in those without delirium (p < 0.001). This differ-
ence remained in multivariable analysis; delirium pres-
ence was associated with a mean (bootstrapped)
increased length of stay of + 3.45 days (CI 1.75–5.07)
compared to those without (p = 0.001). Possible delirium
was associated with increased length of stay when com-
pared to patients without delirium (+ 2.21 days, CI 0.27–
4.52; p = 0.038); 4AT-positive status with no evidence of
delirium was not associated with increased length of stay
(Table 2; Additional file 2: Tables S7-S8). Further post
hoc tests are included in Additional file 2: Tables S9-
S11. There was no association of delirium recognition or
subtype with length of stay (Additional file 2: Tables S12
and S13).
Delirium and mortality
The presence of DSM-5 delirium was associated with in-
creased mortality at 1 month both before (OR 3.02, CI
1.88–4.87; p < 0.001) and after adjusting for other vari-
ables: age, gender, frailty, specialty, and dementia (OR
2.43, CI 1.44–4.09; p = 0.001) (Table 3). Delirium was
also associated with increased mortality in time-to-event
analysis (HR 1.62, CI 1.00–2.61; p = 0.048) (Table 4).
Possible delirium was associated with increased odds of
death in univariable but not multivariable analysis (Add-
itional file 2: Table S14). Similarly, 4AT-positive status
was associated with increased odds of death in multivari-
able analysis (OR 2.55, CI 1.53–4.24; p < 0.001) (Add-
itional file 2: Table S15). There was no effect of delirium
recognition or subtype upon mortality (Additional file 2:
Tables S16 and S17).
Discussion
In this multi-centre study of delirium in older acute hos-
pital admissions, delirium was prevalent and associated
with significant adverse outcomes. Delirium was more
common in individuals with dementia and frailty. Delir-
ium screening and recognition were both low. Import-
antly, higher screen rates were associated with fivefold
higher recognition rates, demonstrating the need for
screening in clinical practice. Delirium was associated
with increased mortality and length of stay within
one month of admission; this association remained after
adjusting for age and frailty.
Results in the context of other literature
Prevalence of delirium was lower than a previous single-
site point prevalence study (14.7% vs. 19.6%) [5]. How-
ever, our study focussed on new admissions only;
hospital-wide point prevalence may be higher including
cases of incident delirium. Positive 4AT status preva-
lence was similar to a multihospital study [26]. Increased
delirium prevalence was associated with age and demen-
tia, as previously described [27, 28]. Prevalence of differ-
ent delirium subtypes was similar to results published
elsewhere [29].
Screening and recognition rates were similar to previ-
ous results [4, 18]. This is the first study to identify dif-
ferences in delirium screening and recognition rates
across specialties. Specialty was not predictive of delir-
ium presence after adjusting for age, frailty, and demen-
tia; specialty alone does not affect chances of delirium.
However, individuals admitted under surgery were 3
times less likely to be screened for delirium and 20 times
less likely to be recognised as having delirium. This may
be related to the training and skill set of responsible
healthcare staff.
Documentation of delirium on discharge summaries
was poor. This was not affected by any hospital or
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Fig. 2 (See legend on next page.)
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patient factors. However, this effect is not unique to delir-
ium; a similar rate of poor communication has been de-
scribed across multiple settings [30]. A multitude of quality
improvement projects has suggested techniques to improve
discharge communication with varying success [31–33].
Small studies have demonstrated that frailty in-
creases the risk of delirium [34–37] and is associated
with greater mortality in delirium [37]. This is the
largest study to examine this association. Patients
with severe frailty were nine times more likely to
have delirium, and delirium and frailty were inde-
pendent risks of mortality and increased length of
stay. The CFS is a widely used and valid method of
measuring frailty in clinical practice [25], which can
be used with minimal training by non-specialists [38].
We have uniquely demonstrated that frail patients
were far less likely to have delirium recognised. This
may be due to increased misdiagnosis as chronic cog-
nitive impairment and a perception that features are
“expected” for patients with frailty in hospital. By
contrast, healthcare professionals may have a different
subconscious bias in how they “expect” fit patients to
present in hospital. Although we included cases of
probable dementia as well as known dementia, it is
likely that there were other patients who had undiag-
nosed dementia and additional patients with mild
cognitive impairment; one fifth of patients with delir-
ium have been shown to have undiagnosed dementia
[39]. Frailty and cognitive impairment commonly co-
exist [40]; therefore, some of the effects of reduced
recognition of delirium may relate to pre-existent
cognitive impairment.
What is the internal validity of our research?
There are a number of important limitations. Firstly,
usual clinical teams were informed of screening and
diagnosis results; this may have moderated effects of
non-recognition on outcomes. However, only a single
study to date has found an association between non-
recognition and adverse outcomes [41]. Secondly, non-
specialists (healthcare staff other than geriatricians or
psychiatrists) carried out the assessments. However,
standardised training was provided to assessors, a struc-
tured proforma was used for assessment, and positive re-
sults were discussed with a local expert. In fact, delirium
prevalence was slightly lower than previously published,
suggesting if anything this method led to a higher speci-
ficity (i.e. fewer false positives). This in itself can be con-
sidered a limitation, although we purposefully used a
strict interpretation of the DSM-5 criteria. The specifi-
city of the 4AT against DSM-4 has previously been re-
ported at 84.7%, whereas only 58.6% of 4AT-positive
patients were considered to have DSM-5 delirium [21].
Thirdly, delirium tends to fluctuate, and delirium may
not have been present when reviewed by the usual care
team. The nature of delirium ascertainment was such
(See figure on previous page.)
Fig. 2 a Prevalence of recognised and unrecognised delirium by specialty. The total of each bar represents the overall prevalence of delirium within
each specialty; standard error bars show the 95% confidence intervals of prevalence by specialty. The yellow portion of each bar represents recognised
delirium, and the red portion of each bar represents unrecognised delirium. Prevalence differed between specialties; however, after controlling for
other confounders (e.g. age), specialty was not predictive of delirium prevalence. There were reduced odds of recognition of delirium in patients
admitted to general, other, or orthopaedic surgery as compared to acute medicine. b Screening of delirium by specialty. Each bar represents the total
percentage of patients who were screened for delirium by the usual care team prior to assessment as part of this study within each specialty; the
standard error bars show the 95% confidence intervals of percentage screened. Reduced odds of screening for delirium were exhibited in patients
admitted under general or other surgery as compared to acute medicine
Table 2 Results of post hoc tests of mean difference following robust (bootstrapped) ANCOVA. The presence of delirium was
associated with an increased length of stay of 3.45 days. Considering possible delirium separately, there was an increased length of
stay of 2.21 days compared to those without delirium. Results of statistical significance (p<0.005) have been highlighted in bold
Status (a) Status (b) Mean
difference
(a − b)
Bootstrap
Bias SE p 95% confidence interval
Lower Upper
No or possible delirium Delirium − 3.45 0.017 0.84 0.001 − 5.07 − 1.75
No delirium 4AT positive, no delirium − 2.55 − 0.01 1.35 0.052 − 5.21 0.04
Possible delirium − 2.21 − 0.07 1.08 0.038 − 4.52 − 0.27
Delirium − 3.95 − 0.02 0.91 0.001 − 5.78 − 2.22
4AT positive, no delirium Possible delirium 0.34 − 0.06 1.65 0.820 − 3.00 3.61
Delirium − 1.41 − 0.01 1.50 0.35 − 4.35 1.69
Possible delirium Delirium − 1.74 0.05 1.31 0.183 − 4.19 0.89
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that we may have missed delirium in those who were
4AT negative. Using the published sensitivity of the 4AT
as 89.7% [21], we estimate this to be 25 of the 1141 who
were 4AT negative. Therefore, results comparing out-
comes between delirium and no delirium should be
treated with caution. We suggest that given the well-
described association of delirium to mortality, this is
likely to have tempered our published results.
What are the messages for routine clinical practice?
Specialist delirium teams have developed in hospitals
in recent years with an aim to improve delirium man-
agement. Delirium teams improved the likelihood of
delirium screening but actually reduced the likelihood
of recognition. This contradiction could be due to in-
herent differences in how a delirium team diagnose
delirium. Alternative solutions to improve routine de-
lirium screening (e.g. embedded screening tools in ad-
mission documentation) were not associated with
better screening rates. In the UK, 4AT screening in
older trauma patients is financially driven; screening
was similar to acute medicine, and yet recognition
was reduced [42]. We consider that, although screen-
ing can improve recognition, wider training is needed
alongside this. Trusts wishing to invest in delirium
teams should ensure adequate training is provided to
team members. We did not collect data on if formal
delirium education or screening training had been
targeted towards certain wards within individual hos-
pitals. We were, therefore, unable to assess for intra-
hospital factors that may lead to local variations
within the same hospital, beyond specialty itself.
Possible delirium was defined as meeting individual
but not all reference standard criteria. We consider
this synonymous with subsyndromal delirium, defined
as the presence of one or more symptoms of delir-
ium, not meeting criteria for or progressing to delir-
ium [43]. Standardised criteria to aid diagnosis do not
exist; however, it is increasingly recognised as an im-
portant condition in its own right. Associations with
increased length of stay [44], institutionalisation [45],
and mortality [45] have been demonstrated. We re-
port similar results. The majority of individuals with
a positive 4AT score had either possible or definite
delirium, and 4AT-positive status by itself predicts
adverse outcomes. This highlights the value of the
4AT to identify those at high risk and reiterates that
screening should become routine practice. We suggest
that in an acute hospital environment, a positive 4AT
highlights patients at increased risk of adverse out-
come. We recommend pairing of a comprehensive de-
lirium management strategy (such as the TIME
Bundle from the Scottish Delirium Association) [46].
Conclusions
Within the UK, delirium is highly prevalent amongst
older hospital inpatients across specialties. Delirium is a
severe condition associated with increased length of stay
and mortality. Older adults with frailty are particularly
vulnerable to delirium, and as frailty is associated with
adverse outcomes in its own right, these patients exhibit
greatest vulnerability. Unfortunately, our results suggest
that delirium is less likely to be recognised in the frailest
patients. We recommend that national quality improve-
ment strategies should be implemented to increase
screening and recognition of delirium, particularly focus-
sing on patients with frailty and those admitted under
surgical specialties.
Table 3 Effect of delirium status upon odds of mortality within 30 days. Delirium was associated with an increased odds of death
within 30 days both unadjusted and adjusted for other confounders. Of those other confounders measured, only being very frail (CFS
7–9) was associated with increased odds to death to 30 days. Results of statistical significance (p<0.005) have been denoted with *
Coefficient SE Wald Freedom p OR 95% confidence interval for OR
Lower Upper
Delirium (unadjusted) 1.10 0.24 20.62 1 < 0.001* 3.02 1.88 4.87
Delirium (adjusted)† 0.89 0.27 11.02 1 0.001* 2.43 1.44 4.09
Very frail (adjusted)‡ 0.95 0.38 6.20 1 0.013* 2.59 1.23 5.48
†Adjusted for age, gender, CFS, dementia status, and specialty
‡Adjusted for delirium status, age, dementia status, and specialty
Table 4 Effect of delirium status upon time to death with follow-up to 30 days. The presence of delirium was associated with a
greater risk of an earlier death; no other variables were significant in time to death analysis
Coefficient SE Wald Freedom p HR 95% confidence interval for OR
Lower Upper
Delirium (unadjusted) 0.58 0.23 6.25 1 0.012 1.78 1.13 2.81
Delirium (adjusted)† 0.48 0.24 3.90 1 0.048 1.62 1.00 2.61
†Adjusted for age, gender, CFS, dementia status, and specialty
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